Statistical considerations for study design, randomization, estimation, and monitoring

Wed, Aug 9, 2:00 PM

Gail PotterChair

Biometrics Section

6 Presentations

WITHDRAWN Conditional maximum likelihood for mixed models under two-phase designs

2:05 PM - 2:20 PM

Co-authors: Yi Xue

Design and analysis of clinical trials in the presence of racial disparity

2:20 PM - 2:35 PM

Chengjie Xiong (Washington University in St Louis)

Co-authors: Jingqin Luo (Washington University in St. Louis), Quoc Bui (Washington University in St. Louis), Ruijin Lu, John Morris (Washington University in St. Louis)

Designing stepped wedge cluster randomized trials with a baseline measurement of the outcome

2:35 PM - 2:50 PM

Kendra Plourde (Yale University)

Co-authors: Keith Goldfeld (NYU School of Medicine), Monica Taljaard (Ottawa Hospital Research Institute), Fan Li (Yale School of Public Health)

Flexible Multistage Design With Both Safety and Efficacy Using the Predicted Probability

2:50 PM - 3:05 PM

Gregory JM Zajac (Incyte Corporation)

Co-authors: Qingyang Liu (University of Connecticut), Feng Zhou, Jason JZ Liao (Incyte Corporation)

Covid-19 Vaccines: Efficacy Evaluation with Initial Clinical Trial Data – Accuracy and Caveats

3:05 PM - 3:20 PM

Wenjiang Fu (University of Houston)

Co-authors: Jieni Li (University of Houston), Paul Scheet

Sequential Monitoring in N-of-1 Trials

3:20 PM - 3:35 PM

Subodh Selukar

Co-authors: David K. Prince (University of Washington), Susanne May (University of Washington)

Session participants

Ana Maria Ortega-Villa (National Institutes of Health)

Participant